Small Molecule Tyrosine Kinase Inhibitors: The New Dawn for Cancer Therapy

Publisher： Bentham Science Publishers

E-ISSN： 1875-628x|9|1|84-125

ISSN： 1570-1808

Source： Letters in Drug Design & Discovery, Vol.9, Iss.1, 2012-01, pp. : 84-125

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Small Molecule FLT3 Tyrosine Kinase Inhibitors

By  

Current Pharmaceutical Design, Vol. 10, Iss. 11, 2004-04 ,pp. : 1183-1193

Bentham Science Publishers

Access to resources Recommend Favorite

Small Molecule Kinase Inhibitors as Anti-Cancer Therapeutics

By  

Mini Reviews in Medicinal Chemistry, Vol. 12, Iss. 5, 2012-05 ,pp. : 399-411

Bentham Science Publishers

Access to resources Recommend Favorite

Small molecule tyrosine kinase inhibitors: clinical development of anticancer agents

By Laird A Douglas   Cherrington Julie M  

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 1, 2003-01 ,pp. : 51-64

Informa Healthcare

Access to resources Recommend Favorite

Small Molecule Inhibitors of the Class 1 Receptor Tyrosine Kinase Family

By  

Current Topics in Medicinal Chemistry, Vol. 2, Iss. 9, 2002-09 ,pp. : 1001-1010

Bentham Science Publishers

Access to resources Recommend Favorite

Small Molecule Inhibitors of STAT3 for Cancer Therapy

By  

Current Medicinal Chemistry, Vol. 18, Iss. 26, 2011-09 ,pp. : 4012-4018

Bentham Science Publishers

Access to resources Recommend Favorite